The latest research related to the treatment of patients with COPD is often first made public at the annual CHEST meeting. In this CME activity, Barbara Yawn, MD, provides an introduction related to the role of triple inhaled therapy in selected patients with COPD to treat symptoms and prevent exacerbations. She discusses 3 posters presented at the 2021 CHEST meeting related to triple therapy. Dr. Yawn first summarizes the methods and results of each of these posters, then provides her own thoughts as to the importance of the research findings and implications for clinical practice in the treatment of patients with COPD.
0.75 AMA PRA Category 1 CreditsTM
This activity is intended for pulmonologists, allergists, critical care specialists, primary care physicians, and other clinicians involved in the management of patients with COPD.
This activity is supported by an educational grant from AstraZeneca.